Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Applovin Corporation (APP) vs Tilray Brands Inc (TLRY) Price & Performance

Applovin CorporationTrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

Applovin Corporation vs Tilray Brands Inc — how do they compare? Applovin Corporation trades at $319 (market cap $113.45B), while Tilray Brands Inc trades at $4.76 (market cap $601.34M). The key difference: Applovin Corporation is far larger — about 188.7× Tilray Brands Inc's market cap. Which is the better fit depends on your goals.

APPTLRY
Market Cap
$113.45B$601.34M
Sector
TechnologyHealth
52-Week High
$733.60$21.00
52-Week Low
$335.67$3.88
Enterprise Value
$113.91B$768.47M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Applovin Corporation

AppLovin (APP) trades at $346.80, down 3.32% amid a bearish technical outlook despite strong fundamentals. The stock faces selling pressure after Q2 revenue missed expectations, though it maintains exceptional profitability with 64.58% net margins and 53% YoY revenue growth. Analyst consensus remains bullish with an $569.60 price target, but technical indicators show 18 sell signals versus 2 buys.

The stock presents a growth-at-a-reasonable-price opportunity post-selloff, trading at 26x P/E with 80% analyst buy ratings. Key risks include execution volatility in AI-driven ad pricing and high valuation multiples. Upside depends on Q3 results meeting elevated guidance of 47% growth.

Tilray Brands Inc

TLRY trades at $4.57, up 2.93% with a bullish technical signal, though recent earnings misses and negative profitability metrics highlight fundamental challenges. The company reported record fiscal 2026 revenue of $915 million but continues to post significant net losses. Analyst sentiment is mixed with 25% buy ratings, while technical indicators show RSI near overbought levels with key support at $4.

Outlook remains cautious due to persistent losses and high valuation multiples, though revenue growth and diversification into beverages offer potential upside. Key risks include execution challenges, cannabis regulatory uncertainty, and competitive pressures in the consumer goods space.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Applovin Corporation

AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.

Read more on APP

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY